Adapthealth 's Revenue in the fiscal year 2025 $ 3,244.86 millions
Adapthealth 's Revenue in the fiscal year 2024 $ 3,260.98 millions
Adapthealth 's Revenue in the fiscal year 2023 $ 3,200.18 millions
Adapthealth 's Revenue in the fiscal year 2022 $ 2,970.60 millions
Adapthealth 's Revenue in the fiscal year 2021 $ 2,454.54 millions
AHCO Revenue second quarter 2026 Y/Y Growth Comment
Adapthealth Corp reported decrease in Revenue in the second quarter 2026 by -7.5% to $ 740.31 millions, from the same quarter in 2025. The decrease in the second quarter 2026 Adapthealth Corp 's Revenue compares unfavorably to the Company's average Revenue rise of 21.53%.
Looking into second quarter 2026 results within Healthcare Facilities industry 24 other companies have achieved higher Revenue growth. While Adapthealth Corp ' s Revenue decline of -7.5% ranks overall at the positon no. 2474 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Adapthealth 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
38.37 %
-0.28 %
-100 %
(Mar 31 2021)
AHCO's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Adapthealth Corp disclosed drop in Revenue from the first quarter by -9.7% to $ 740.31 millions, from $ 819.80 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Healthcare Facilities's company achievement, Most analysts pointed out.
Within Healthcare Facilities industry 37 other companies have achieved higher Revenue quarter on quarter growth. While Adapthealth 's Revenue growth quarter on quarter, overall rank is 2706.
In the II. Quarter 2026 Adapthealth Corp disclosed drop in Revenue from the first quarter by -9.7% to $ 740.31 millions, from $ 819.80 millions achived in the previous reporting period.
Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Healthcare Facilities's company achievement, Most analysts pointed out.
Within Healthcare Facilities industry 37 other companies have achieved higher Revenue quarter on quarter growth. While Adapthealth 's Revenue growth quarter on quarter, overall rank is 2706.
Adapthealth 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 3,226.71
$ 3,286.77
$ 3,244.86
$ 3,255.21
$ 3,240.76
Y / Y Revenue Growth (TTM)
-0.43 %
1.24 %
-0.49 %
-0.23 %
-0.61 %
Year on Year Revenue Growth Overall
Ranking
# 2547
# 2455
# 1542
# 1695
# 997
Seqeuential Revenue Change (TTM)
-1.83 %
1.29 %
-0.32 %
0.45 %
-0.17 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2474
# 2495
# 1707
# 1501
# 1476
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 Adapthealth reported a decrease in Revenue by -0.43% year on year, to $3,227 millions, compare to the 1.24% growth at Mar 31 2026.
In the Healthcare sector 370 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2455 to 2547.
For the 12 months ended Jun 30 2026 Adapthealth reported a decrease in Revenue by -0.43% year on year, to $3,227 millions, compare to the 1.24% growth at Mar 31 2026.
In the Healthcare sector 370 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2455 to 2547.
About Adapthealth Revenue Growth Rates (AHCO), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
